Yot Teerawattananon

13.9k total citations · 3 hit papers
241 papers, 8.4k citations indexed

About

Yot Teerawattananon is a scholar working on Economics and Econometrics, General Health Professions and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Yot Teerawattananon has authored 241 papers receiving a total of 8.4k indexed citations (citations by other indexed papers that have themselves been cited), including 120 papers in Economics and Econometrics, 56 papers in General Health Professions and 44 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Yot Teerawattananon's work include Health Systems, Economic Evaluations, Quality of Life (101 papers), Healthcare Systems and Reforms (39 papers) and Healthcare Policy and Management (38 papers). Yot Teerawattananon is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (101 papers), Healthcare Systems and Reforms (39 papers) and Healthcare Policy and Management (38 papers). Yot Teerawattananon collaborates with scholars based in Thailand, Singapore and United Kingdom. Yot Teerawattananon's co-authors include Montarat Thavorncharoensap, Jürgen Rehm, Jayadeep Patra, Colin Mathers, Svetlana Popova, Mark Jit, Sripen Tantivess, Olivier J. Wouters, Heidi J. Larson and Maximilian Salcher‐Konrad and has published in prestigious journals such as Nature, The Lancet and Nature Medicine.

In The Last Decade

Yot Teerawattananon

226 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders

2009 2.6k citations Jürgen Rehm, Colin Mathers et al. The Lancet profile →
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment

2021 821 citations Olivier J. Wouters, Yot Teerawattananon et al. The Lancet profile →
Adjusting for Inflation and Currency Changes Within Health Economic Studies

2019 205 citations Yot Teerawattananon, Mark Jit et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Yot Teerawattananon Thailand	39	2.5k	2.2k	1.9k	1.3k	928	241	8.4k
A. Mark Fendrick United States	53	1.4k 0.6×	3.3k 1.5×	2.2k 1.1×	661 0.5×	433 0.5×	359	11.7k
André Pascal Kengne South Africa	64	3.7k 1.5×	1.1k 0.5×	1.9k 1.0×	374 0.3×	550 0.6×	580	20.5k
Dana P. Goldman United States	53	1.6k 0.6×	4.0k 1.8×	3.4k 1.8×	213 0.2×	1.1k 1.2×	324	11.5k
Martin Gulliford United Kingdom	61	2.6k 1.0×	1.7k 0.8×	3.5k 1.8×	226 0.2×	646 0.7×	319	14.8k
Nathorn Chaiyakunapruk United States	49	1.6k 0.6×	1.2k 0.6×	881 0.5×	478 0.4×	310 0.3×	359	10.0k
Kenji Shibuya Japan	47	1.8k 0.7×	829 0.4×	2.5k 1.3×	284 0.2×	1.2k 1.3×	192	13.7k
Théodore G. Ganiats United States	46	2.2k 0.9×	2.4k 1.1×	2.5k 1.3×	494 0.4×	399 0.4×	131	22.8k
Jeroan J. Allison United States	62	2.2k 0.9×	1.4k 0.7×	3.8k 2.0×	362 0.3×	880 0.9×	334	12.5k
Kar Keung Cheng United Kingdom	56	1.5k 0.6×	686 0.3×	1.5k 0.8×	594 0.5×	486 0.5×	401	11.8k
Don Husereau Canada	34	1.2k 0.5×	3.1k 1.4×	1.7k 0.9×	287 0.2×	259 0.3×	110	9.2k

Countries citing papers authored by Yot Teerawattananon

Since Specialization

Citations

This map shows the geographic impact of Yot Teerawattananon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yot Teerawattananon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yot Teerawattananon more than expected).

Fields of papers citing papers by Yot Teerawattananon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yot Teerawattananon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yot Teerawattananon. The network helps show where Yot Teerawattananon may publish in the future.

Co-authorship network of co-authors of Yot Teerawattananon

This figure shows the co-authorship network connecting the top 25 collaborators of Yot Teerawattananon. A scholar is included among the top collaborators of Yot Teerawattananon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yot Teerawattananon. Yot Teerawattananon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Teerawattananon, Yot, et al.. (2025). The way home: a scoping review of public health interventions to increase the utilization of home dialysis in chronic kidney disease patients. BMC Nephrology. 26(1). 169–169. 3 indexed citations

Teerawattananon, Yot, et al.. (2025). Balancing patient choice and health system capacity: a system dynamics model of dialysis in Thailand. BMC Medicine. 23(1). 646–646. 1 indexed citations

Teerawattananon, Yot, et al.. (2025). A case study integrating scenario thinking with dialysis policymaking in Thailand. Communications Medicine. 6(1). 44–44.

Hadisoemarto, Panji Fortuna, et al.. (2025). Guidelines for the use of economic evaluation to inform policies around access to treatment for kidney failure. Nature Reviews Nephrology. 21(12). 859–877.

Teerawattananon, Yot, et al.. (2025). WCN25-4040 SYSTEMATIC REVIEW OF STRATEGIES TO INCREASE UPTAKE OF COMPREHENSIVE CONSERVATIVE CARE FOR ADVANCED CHRONIC KIDNEY DISEASE PATIENTS. Kidney International Reports. 10(2). S83–S84. 3 indexed citations

Ashley, Elizabeth A., et al.. (2025). Situation analysis of evidence-informed health decision-making in Lao PDR: the case of health technology assessment. The Lancet Regional Health - Western Pacific. 57. 101534–101534. 1 indexed citations

Merlin, Tracy, Christian Suharlim, Manuel Espinoza, et al.. (2024). Good Practices for Health Technology Assessment Guideline Development: A Report of the Health Technology Assessment International, HTAsiaLink, and ISPOR Special Task Force. International Journal of Technology Assessment in Health Care. 40(1). e74–e74. 2 indexed citations

Pongsachareonnont, Pear, Phantipa Sakthong, Voraporn Chaikitmongkol, et al.. (2024). Health Utility Values Among Patients With Diabetic Retinopathy, Wet Age-Related Macular Degeneration, and Cataract in Thailand: A Multicenter Survey Using Time Trade-Off, EQ-5D-5L, and Health Utility Index 3. Value in Health Regional Issues. 44. 101030–101030. 1 indexed citations

Teerawattananon, Yot, Chris Painter, Saudamini Vishwanath Dabak, et al.. (2021). Avoiding health technology assessment: a global survey of reasons for not using health technology assessment in decision making. Cost Effectiveness and Resource Allocation. 19(1). 62–62. 19 indexed citations

10.

Lou, Jing, et al.. (2021). Protocol for the economic evaluation of COVID-19 pandemic response policies. BMJ Open. 11(9). e051503–e051503. 3 indexed citations

11.

Jit, Mark, et al.. (2021). Multi-country collaboration in responding to global infectious disease threats: lessons for Europe from the COVID-19 pandemic. The Lancet Regional Health - Europe. 9. 100221–100221. 56 indexed citations

12.

Painter, Chris, Wanrudee Isaranuwatchai, Hwee Lin Wee, et al.. (2021). Avoiding Trouble Ahead: Lessons Learned and Suggestions for Economic Evaluations of COVID-19 Vaccines. Applied Health Economics and Health Policy. 19(4). 463–472. 4 indexed citations

13.

Painter, Chris, et al.. (2021). A protocol for a systematic literature review of economic evaluation studies of interventions to address antimicrobial resistance. Systematic Reviews. 10(1). 242–242. 6 indexed citations

14.

Tangjitgamol, Siriwan, et al.. (2020). Cost–utility analysis of adjuvant chemotherapy after concurrent chemoradiation in patients with locally advanced cervical cancer. Journal of Medical Imaging and Radiation Oncology. 64(6). 873–881. 4 indexed citations

15.

Witthayapipopsakul, Woranan, et al.. (2020). Prioritizing critical-care resources in response to COVID-19: lessons from the development of Thailand's Triage protocol. International Journal of Technology Assessment in Health Care. 36(6). 540–544. 2 indexed citations

16.

Cohen, Joshua T., Kalipso Chalkidou, Yot Teerawattananon, et al.. (2019). Adherence to the iDSI reference case among published cost-per-DALY averted studies. PLoS ONE. 14(5). e0205633–e0205633. 27 indexed citations

17.

Kristin, Erna, et al.. (2017). Economic evaluation of policy options for dialysis in end-stage renal disease patients under the universal health coverage in Indonesia. PLoS ONE. 12(5). e0177436–e0177436. 46 indexed citations

18.

Teerawattananon, Yot, Sripen Tantivess, Nattha Tritasavit, et al.. (2016). The influence of cost-per-DALY information in health prioritisation and desirable features for a registry: a survey of health policy experts in Vietnam, India and Bangladesh. Health Research Policy and Systems. 14(1). 86–86. 5 indexed citations

19.

Thavorncharoensap, Montarat, et al.. (2013). Estimating the willingness to pay for a quality-adjusted life year in Thailand: does the context of health gain matter?. SHILAP Revista de lepidopterología. 5 indexed citations

20.

Rehm, Jürgen, Colin Mathers, Svetlana Popova, et al.. (2009). Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. The Lancet. 373(9682). 2223–2233. 2620 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact